ID: ALA5283631

Max Phase: Preclinical

Molecular Formula: C14H22N2O2

Molecular Weight: 250.34

Associated Items:

Representations

Canonical SMILES:  CC(C)CCCCCC(=O)Nc1ccc(O)cn1

Standard InChI:  InChI=1S/C14H22N2O2/c1-11(2)6-4-3-5-7-14(18)16-13-9-8-12(17)10-15-13/h8-11,17H,3-7H2,1-2H3,(H,15,16,18)

Standard InChI Key:  SGRNXNAJGRDAAB-UHFFFAOYSA-N

Associated Targets(Human)

Sphingolipid delta(4)-desaturase DES1 28 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 250.34Molecular Weight (Monoisotopic): 250.1681AlogP: 3.33#Rotatable Bonds: 7
Polar Surface Area: 62.22Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.75CX Basic pKa: 3.98CX LogP: 3.49CX LogD: 3.48
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.73Np Likeness Score: -0.39

References

1. Skácel J, Slusher BS, Tsukamoto T..  (2021)  Small Molecule Inhibitors Targeting Biosynthesis of Ceramide, the Central Hub of the Sphingolipid Network.,  64  (1.0): [PMID:33395289] [10.1021/acs.jmedchem.0c01664]

Source